REQUEST A DEMO
Total
USD $0.00
Search more companies

Dongkoo Bio & Pharma Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Dongkoo Bio & Pharma Co.,Ltd. Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dongkoo Bio & Pharma Co.,Ltd. is an enterprise located in South Korea, with the main office in Seoul. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. Dongkoo Bio & Pharma Co.,Ltd. was incorporated on July 01, 1983. 101 - 500 (2025) employees currently work for Dongkoo Bio & Pharma Co.,Ltd.. The latest financial highlights indicate a net sales revenue drop of 5.68% in Q3C2025. A growth of 13.22% was recorded in its total assets. In, 2025, the company’s net profit margin decreased by 0.39%.

Headquarters
14F, B-Dong, 114, Beopwon-Ro, Songpa-Gu
Seoul; Seoul;

Contact Details: Purchase the Dongkoo Bio & Pharma Co.,Ltd. report to view the information.

Website: http://www.dongkoo.com

Basic Information
Total Employees:
Purchase the Dongkoo Bio & Pharma Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Dongkoo Bio & Pharma Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Dongkoo Bio & Pharma Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Dongkoo Bio & Pharma Co.,Ltd. report to view the information.
Incorporation Date:
July 01, 1983
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
27.7%
Purchase this report to view the information.
11.2%
Purchase this report to view the information.
3.5%
Subsidiaries
(주)노바셀테크놀로지
Company Performance
Financial values in the chart are available after Dongkoo Bio & Pharma Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-5.68%
Total Operating Revenue
-1.04%
Operating Profit
26.31%
EBITDA
25.97%
Net Profit/Loss for the Period
-12.56%
Total Assets
13.22%
Total Equity
-3.45%
Operating Profit Margin
1.61%
Net Profit Margin
-0.39%
Return on Equity (ROE)
-0.84%
Debt / Equity
30.91%
Quick Ratio
-0.13%
Cash Ratio
-0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?